NCT02071888 · Interventional trial
Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors
Overall registry status Completed
Phase 1
Conditions Multiple Myeloma, Non-Hodgkin's Lymphoma (NHL), Other B-cell NHL Subtypes, Including WM, T-cell NHL, Waldenstrom's Macroglobulinemia (WM)
Delaware Valley sites
- University of Pennsylvania, Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory